Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (Q28244389)
Jump to navigation
Jump to search
scientific article (publication date: September 2007)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial |
scientific article (publication date: September 2007) |
Statements
Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial (English)
Sandeep T Patil
Lu Zhang
Ferenc Martenyi
Stephen L Lowe
Kimberley A Jackson
Alla S Avedisova
Issak Y Gurovich
Nikolai G Neznanov
Alexander M Reznik
Vladimir A Tochilov
Bryan G Johnson
James A Monn
Darryle D Schoepp
Identifiers
2 references
2 references